Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis


Pfizer Inc. (NYSE: PFE) today announced detailed results from two pivotal studies that make up the ELEVATE UC Phase 3 registrational program evaluating etrasimod, a once-daily, oral, selective

Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis


Pfizer Inc. (NYSE: PFE) today announced detailed results from two pivotal studies that make up the ELEVATE UC Phase 3 registrational program evaluating etrasimod, a once-daily, oral, selective

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU releases strong full-year results and expects significant growth in FY 2022/2023
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU releases strong full-year results and expects significant growth in FY 2022/2023
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU releases strong full-year results and expects significant growth in FY 2022/2023
Nordson Corporation Reports Strong Second Quarter Fiscal 2022 Results and Raises Annual Earnings Guidance: https://mms.businesswire.com/media/20191120005506/en/198821/5/Nordson_large.jpg
Nordson Corporation Reports Strong Second Quarter Fiscal 2022 Results and Raises Annual Earnings Guidance


Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal second quarter ended April 30, 2022. Sales were $635 million, an 8% increase compared to the prior year’s second quarter

Advance Auto Parts Reports First Quarter 2022 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24217/330px-Logo_of_Advance_Auto_Parts.svg.png
Advance Auto Parts Reports First Quarter 2022 Results


Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America, that serves both professional installer and do-it-yourself customers, announced its financial

UDR Appoints Joe Fisher to President and CFO: https://mms.businesswire.com/media/20191202005772/en/759858/5/UDR_-_Opening_Doors_to_the_Future_Logo_-_Trademarked.jpg
UDR Appoints Joe Fisher to President and CFO


UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust, announced today that Joseph D. Fisher, 42, has been appointed to the role of President in addition to his

Advisory: Chevron to Present at Bernstein’s 38th Annual Strategic Decisions Conferencehttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png
Advisory: Chevron to Present at Bernstein’s 38th Annual Strategic Decisions Conference


Mike Wirth, chairman and CEO of Chevron Corporation (NYSE: CVX), will take part in the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, at 9:00 AM ET, discussing corporate

Advisory: Chevron to Present at Bernstein’s 38th Annual Strategic Decisions Conferencehttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png
Advisory: Chevron to Present at Bernstein’s 38th Annual Strategic Decisions Conference


Mike Wirth, chairman and CEO of Chevron Corporation (NYSE: CVX), will take part in the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, at 9:00 AM ET, discussing corporate

ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the H.C. Wainwright

Cirrus Logic to Present at Upcoming Conferences
Cirrus Logic to Present at Upcoming Conferences


Cirrus Logic, Inc. (Nasdaq: CRUS) today announced that the company will be presenting at the following investor conferences:




  • New York, June 1 – Cirrus Logic President and Chief Executive Officer

RUBIS: Results from the capital increase reserved for Group employees
RUBIS: Results from the capital increase reserved for Group employees
RUBIS: Results from the capital increase reserved for Group employees
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Diamondx Selected for Internet of Things Semiconductor Test: https://mms.businesswire.com/media/20191106005014/en/502601/5/Cohu_Standard_Color_Logo.jpg
Diamondx Selected for Internet of Things Semiconductor Test


Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today announced a leading U.S. semiconductor manufacturer has selected the Diamondx platform for testing

AIG Releases Second Environmental, Social and Governance (ESG) Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23883/AIG_logo.svg.png
AIG Releases Second Environmental, Social and Governance (ESG) Report


American International Group, Inc. (NYSE: AIG) today released its 2021 Environmental, Social and Governance (ESG) Report.



The 2021 ESG Report builds upon AIG’s inaugural ESG Report published last

Innoviva to Acquire Entasis Therapeutics
Innoviva to Acquire Entasis Therapeutics


Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and Entasis Therapeutics Holdings

DGAP-News: Basler AG: Shareholders of Basler AG approve agenda items of today’s Annual General Meeting with a large majority
DGAP-News: Basler AG: Shareholders of Basler AG approve agenda items of today’s Annual General Meeting with a large majority
DGAP-News: Basler AG: Shareholders of Basler AG approve agenda items of today’s Annual General Meeting with a large majority
NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service


NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on

Advance Auto Parts Announces Innovative, First to Market 12-Volt DieHard Battery Designed Specifically for Hybrid and Electric Vehicles: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24217/330px-Logo_of_Advance_Auto_Parts.svg.png
Advance Auto Parts Announces Innovative, First to Market 12-Volt DieHard Battery Designed Specifically for Hybrid and Electric Vehicles


Advance Auto Parts (NYSE: AAP), a leading automotive aftermarket parts retailer, today announced the introduction of DieHard® EV with xEV by Clarios, becoming the first auto parts retailer to sell

ICON Named Business & Finance Company of the Year and One of Forbes’ Best Employers for Diversity: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Named Business & Finance Company of the Year and One of Forbes’ Best Employers for Diversity


ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, has been

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dosehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dosehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc